US 10766892
GLS1 inhibitors for treating disease
granted A61KA61K31/4192A61K31/433
Quick answer
US patent 10766892 (GLS1 inhibitors for treating disease) held by The Board of Regents of the University of Texas System expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4192, A61K31/433, A61K31/4439, A61K31/444